Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.150 | 3.150 | 0.000 |
Stocks | 96.730 | 96.730 | 0.000 |
Other | 0.120 | 0.120 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.928 | 23.725 |
Price to Book | 3.516 | 4.780 |
Price to Sales | 2.801 | 3.597 |
Price to Cash Flow | 14.365 | 16.585 |
Dividend Yield | 1.624 | 1.230 |
5 Years Earnings Growth | 14.148 | 12.550 |
Name | Net % | Category Average |
---|---|---|
Technology | 22.510 | 28.833 |
Healthcare | 16.550 | 14.660 |
Consumer Cyclical | 12.600 | 12.529 |
Financial Services | 12.560 | 14.083 |
Industrials | 11.900 | 11.994 |
Communication Services | 11.130 | 8.930 |
Basic Materials | 4.320 | 3.757 |
Consumer Defensive | 4.300 | 6.475 |
Energy | 2.700 | 2.657 |
Utilities | 0.980 | 2.318 |
Real Estate | 0.450 | 1.860 |
Number of long holdings: 255
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 3.78 | 705.45 | +1.15% | |
Microsoft | US5949181045 | 3.26 | 412.50 | +0.38% | |
Taiwan Semicon | TW0002330008 | 3.23 | 1,085.00 | +1.40% | |
Broadcom | US11135F1012 | 2.79 | 220.80 | +1.41% | |
Novo Nordisk B | DK0062498333 | 2.50 | 592.6 | -1.18% | |
NVIDIA | US67066G1040 | 2.24 | 118.65 | +1.71% | |
Tesla | US88160R1014 | 1.96 | 386.37 | +0.70% | |
AstraZeneca | GB0009895292 | 1.58 | 11,030.0 | -2.18% | |
Eli Lilly | US5324571083 | 1.51 | 816.43 | +0.74% | |
Netflix | US64110L1061 | 1.41 | 987.24 | +0.85% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CapGroup NewPerspectiveLux Cadh AUD | 16.62B | 19.66 | 3.77 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review